Sphingosine 1-phosphate: A Potential Molecular Target for Ovarian Cancer Therapy?

被引：29
|
作者：
Dai, Lan [1 ,2 ]
Xia, Pu [3 ]
Di, Wen [1 ,2 ]
机构：
[1] Shanghai Jiao Tong Univ, Renji Hosp, Dept Obstet & Gynecol, Sch Med, Shanghai 200127, Peoples R China
[2] Fudan Univ, Focus Construct Subject Shanghai Educ Dept, Shanghai Key Lab Gynecol Oncol, Shanghai 200433, Peoples R China
[3] Fudan Univ, Zhongshan Hosp, Dept Endocrinol, Shanghai 200433, Peoples R China
来源：
CANCER INVESTIGATION | 2014年 / 32卷 / 03期
关键词：
Ovarian cancer; Sphingosine; 1-phosphate; Sphingosine kinase; ENDOTHELIAL GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; NECROSIS-FACTOR-ALPHA; UP-REGULATION; TNF-ALPHA; KINASE; SPHINGOSINE-1-PHOSPHATE LYASE; SIGNALING PATHWAY; PROSTATE-CANCER; DOWN-REGULATION;
D O I：
10.3109/07357907.2013.876646
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Sphingosine 1-phosphate (S1P) is an important signaling regulator involved in tumor progression in multiple neoplasms. However, the role of S1P in the pathogenesis of ovarian cancer remains unclear. Herein, we summarize recent advances in understanding the impact of S1P signaling in ovarian cancer progression. S1P, aberrantly produced in ovarian cancer patients, is involved in the regulation of key cellular processes that contribute to ovarian cancer initiation and progression. Moreover, agents that block the S1P signaling pathway inhibit ovarian cancer cell growth or induce apoptosis. Hence, current evidence suggests that S1P may become a potential molecular target for ovarian cancer therapy.
引用
收藏
页码：71 / 80
页数：10
相关论文
共 50 条
  • [21] Sphingosine 1-phosphate, a key mediator of the cytokine network: Juxtacrine signaling
    Xia, Pu
    Wadham, Carol
    CYTOKINE & GROWTH FACTOR REVIEWS, 2011, 22 (01) : 45 - 53
  • [22] Sphingosine 1-phosphate and ceramide 1-phosphate: Expanding roles in cell signaling
    Chalfant, CE
    Spiegel, S
    JOURNAL OF CELL SCIENCE, 2005, 118 (20) : 4605 - 4612
  • [23] Sphingosine 1-Phosphate Regulates Obesity and Glucose Homeostasis
    Kajita, Kazuo
    Ishii, Isao
    Mori, Ichiro
    Asano, Motochika
    Fuwa, Masayuki
    Morita, Hiroyuki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)
  • [24] Molecular and physiological functions of sphingosine 1-phosphate transporters
    Nishi, Tsuyoshi
    Kobayashi, Naoki
    Hisano, Yu
    Kawahara, Atsuo
    Yamaguchi, Akihito
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2014, 1841 (05): : 759 - 765
  • [25] Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy
    Huwiler, Andrea
    Zangemeister-Wittke, Uwe
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 63 (02) : 150 - 159
  • [26] Sphingosine kinase and sphingosine 1-phosphate in the heart: A decade of progress
    Karliner, Joel S.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2013, 1831 (01): : 203 - 212
  • [27] Sphingosine 1-Phosphate Signaling and Metabolism in Chemoprevention and Chemoresistance in Colon Cancer
    Grbcic, Petra
    Sedic, Mirela
    MOLECULES, 2020, 25 (10):
  • [28] Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases
    Grassi, Sara
    Mauri, Laura
    Prioni, Simona
    Cabitta, Livia
    Sonnino, Sandro
    Prinetti, Alessandro
    Giussani, Paola
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [29] Ceramide and Sphingosine 1-Phosphate in Liver Diseases
    Park, Woo-Jae
    Song, Jae-Hwi
    Kim, Goon-Tae
    Park, Tae-Sik
    MOLECULES AND CELLS, 2020, 43 (05) : 419 - 430
  • [30] Sphingosine 1-Phosphate Receptors in Cerebral Ischemia
    Gaire, Bhakta Prasad
    Choi, Ji Woong
    NEUROMOLECULAR MEDICINE, 2021, 23 (01) : 211 - 223
12345